Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1998 1
1999 2
2000 2
2001 1
2002 2
2003 2
2004 1
2005 1
2006 1
2007 2
2008 1
2009 4
2010 13
2011 6
2012 6
2013 7
2014 8
2015 5
2016 1
2017 1
2018 1
2019 5
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

68 results
Results by year
Filters applied: . Clear all
Page 1
Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy.
Shi H, Hugo W, Kong X, Hong A, Koya RC, Moriceau G, Chodon T, Guo R, Johnson DB, Dahlman KB, Kelley MC, Kefford RF, Chmielowski B, Glaspy JA, Sosman JA, van Baren N, Long GV, Ribas A, Lo RS. Shi H, et al. Among authors: koya rc. Cancer Discov. 2014 Jan;4(1):80-93. doi: 10.1158/2159-8290.CD-13-0642. Epub 2013 Nov 21. Cancer Discov. 2014. PMID: 24265155 Free PMC article.
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation.
Nazarian R, Shi H, Wang Q, Kong X, Koya RC, Lee H, Chen Z, Lee MK, Attar N, Sazegar H, Chodon T, Nelson SF, McArthur G, Sosman JA, Ribas A, Lo RS. Nazarian R, et al. Among authors: koya rc. Nature. 2010 Dec 16;468(7326):973-7. doi: 10.1038/nature09626. Epub 2010 Nov 24. Nature. 2010. PMID: 21107323 Free PMC article.
Active Immunotherapy of Cancer.
Chodon T, Koya RC, Odunsi K. Chodon T, et al. Among authors: koya rc. Immunol Invest. 2015;44(8):817-36. doi: 10.3109/08820139.2015.1096684. Immunol Invest. 2015. PMID: 26575466 Review.
WHSC1/NSD2 regulates immune infiltration in prostate cancer.
Want MY, Tsuji T, Singh PK, Thorne JL, Matsuzaki J, Karasik E, Gillard B, Cortes Gomez E, Koya RC, Lugade A, Odunsi K, Battaglia S. Want MY, et al. Among authors: koya rc. J Immunother Cancer. 2021 Feb;9(2):e001374. doi: 10.1136/jitc-2020-001374. J Immunother Cancer. 2021. PMID: 33589522 Free PMC article.
Mature neutrophils suppress T cell immunity in ovarian cancer microenvironment.
Singel KL, Emmons TR, Khan ANH, Mayor PC, Shen S, Wong JT, Morrell K, Eng KH, Mark J, Bankert RB, Matsuzaki J, Koya RC, Blom AM, McLeish KR, Qu J, Ram S, Moysich KB, Abrams SI, Odunsi K, Zsiros E, Segal BH. Singel KL, et al. Among authors: koya rc. JCI Insight. 2019 Mar 7;4(5):e122311. doi: 10.1172/jci.insight.122311. eCollection 2019 Mar 7. JCI Insight. 2019. PMID: 30730851 Free PMC article.
Synthesis, Tumor Specificity, and Photosensitizing Efficacy of Erlotinib-Conjugated Chlorins and Bacteriochlorins: Identification of a Highly Effective Candidate for Photodynamic Therapy of Cancer.
Cheruku RR, Cacaccio J, Durrani FA, Tabaczynski WA, Watson R, Siters K, Missert JR, Tracy EC, Dukh M, Guru K, Koya RC, Kalinski P, Baumann H, Pandey RK. Cheruku RR, et al. Among authors: koya rc. J Med Chem. 2021 Jan 14;64(1):741-767. doi: 10.1021/acs.jmedchem.0c01735. Epub 2021 Jan 5. J Med Chem. 2021. PMID: 33400524
Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer.
Liu S, Matsuzaki J, Wei L, Tsuji T, Battaglia S, Hu Q, Cortes E, Wong L, Yan L, Long M, Miliotto A, Bateman NW, Lele SB, Chodon T, Koya RC, Yao S, Zhu Q, Conrads TP, Wang J, Maxwell GL, Lugade AA, Odunsi K. Liu S, et al. Among authors: koya rc. J Immunother Cancer. 2019 Jun 20;7(1):156. doi: 10.1186/s40425-019-0629-6. J Immunother Cancer. 2019. PMID: 31221207 Free PMC article.
68 results